These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28098870)

  • 1. miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells.
    Kim EA; Kim TG; Sung EG; Song IH; Kim JY; Doh KO; Lee TJ
    Int J Oncol; 2017 Mar; 50(3):984-992. PubMed ID: 28098870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells.
    Kim EA; Jang JH; Sung EG; Song IH; Kim JY; Lee TJ
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
    Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
    Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14.
    Li Y; Liu H; Shao J; Xing G
    Mol Med Rep; 2017 Sep; 16(3):2652-2658. PubMed ID: 28713899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14.
    Sun J; Feng X; Gao S; Xiao Z
    Mol Med Rep; 2015 Feb; 11(2):1400-6. PubMed ID: 25374067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Li B; Wang W; Li Z; Chen Z; Zhi X; Xu J; Li Q; Wang L; Huang X; Wang L; Wei S; Sun G; Zhang X; He Z; Zhang L; Zhang D; Xu H; El-Rifai W; Xu Z
    Cancer Lett; 2017 Dec; 410():212-227. PubMed ID: 28965855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2.
    Wen L; Cheng F; Zhou Y; Yin C
    Saudi J Gastroenterol; 2015; 21(5):313-9. PubMed ID: 26458859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine sensitizes ovarian cancer cells to cisplatin through miR-21/PDCD4 axis.
    Liu S; Fang Y; Shen H; Xu W; Li H
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):756-62. PubMed ID: 23824073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
    Liu Y; Niu Z; Lin X; Tian Y
    Cancer Gene Ther; 2017 May; 24(5):208-214. PubMed ID: 28281524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).
    Zhang T; Sun Q; Liu T; Chen J; Du S; Ren C; Liao G; Yuan Y
    Tumour Biol; 2014 Dec; 35(12):12593-9. PubMed ID: 25201065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-144 reverses cisplatin resistance in cervical cancer via targeting LHX2.
    Shi F; Su J; Liu Z; Wang J; Wang T
    J Cell Biochem; 2019 Sep; 120(9):15018-15026. PubMed ID: 31017720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.
    Ye Z; Hao R; Cai Y; Wang X; Huang G
    Tumour Biol; 2016 Apr; 37(4):4509-15. PubMed ID: 26503209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.
    Wu Y; Xiao Y; Ding X; Zhuo Y; Ren P; Zhou C; Zhou J
    PLoS One; 2011; 6(12):e29043. PubMed ID: 22194984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.
    Zuo C; Sheng X; Liu Z; Ma M; Xiong S; Deng H; Li S; Yang D; Wang X; Xiao H; Quan H; Xia M
    Tumour Biol; 2017 Jun; 39(6):1010428317710410. PubMed ID: 28639887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSB affected on the sensitivity of lung cancer cells to platinum-based drugs through the global decrease of let-7 and miR-29.
    Yang Z; Liu C; Wu H; Xie Y; Gao H; Zhang X
    BMC Cancer; 2019 Oct; 19(1):948. PubMed ID: 31615563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.